Observational studyClinical drug investigation2018

Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report).

Tomohiko Takahashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.